Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Julphar
Colorcon
Daiichi Sankyo
Queensland Health
Accenture
UBS
Covington

Generated: June 24, 2018

DrugPatentWatch Database Preview

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cefoxitin And Dextrose In Duplex Container patents expire, and when can generic versions of Cefoxitin And Dextrose In Duplex Container launch?

Cefoxitin And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
Drug patent expirations by year for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
Pharmacology for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
Medical Subject Heading (MeSH) Categories for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
Synonyms for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
(6R,7S)-3-[[(Aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt
33564-30-6
35607-66-0 (acid)
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R-cis)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, sodium salt, (6R-cis)-
AB1009432
AC-1303
AK163512
AKOS024464829
AN-15062
BC202499
Betacef
BIDD:GT0505
C08106
C16H16N3NaO7S2
CAS-33564-30-6
CCG-39693
Cefaxilin Sodium
Cefoxil
Cefoxitin (sodium)
CEFOXITIN NA
CEFOXITIN SODIUM
Cefoxitin sodium (JAN/USP)
Cefoxitin sodium [USAN:USP:BAN:JAN]
Cefoxitin sodium salt
Cefoxitin sodium salt, Antibiotic for Culture Media Use Only
Cefoxitinsodium
Cefoxotin sodium
Cenomycin
CFX
CHEBI:3501
CHEMBL1200530
CPD000058809
CS-4716
CTK8F8533
D00913
DSSTox_CID_28921
DSSTox_GSID_48995
DSSTox_RID_83187
DTXSID8048995
EINECS 251-574-6
Farmoxin
FT-0603033
GNWUOVJNSFPWDD-XMZRARIVSA-M
HE336130
HMS1570H05
HMS1921F14
HMS2092P11
HMS2097H05
HMS2232E15
HMS3259K10
HMS501M18
HY-B1117
L 620388
Mefoxin
Mefoxin (TN)
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
MEFOXIN IN PLASTIC CONTAINER
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Mefoxithin
Mefoxitin
Merxin
MFCD00079042
MK 206
MK 306
MLS000028557
MLS001076334
MLS002222151
MolPort-003-666-398
Monosodium cefoxitin
NC00556
NCGC00183034-01
O877
Opera_ID_912
Prestwick_12
Q68050H03T
SAM002564251
SAM002703131
SCHEMBL41178
Serviflox
SMR000058809
Sodium (6R-cis)-3-((carbamoyloxy)methyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium (6R,7S)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate carbamate (ester)
sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1502031
Tox21_113485
UNII-Q68050H03T

US Patents and Regulatory Information for CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER cefoxitin sodium INJECTABLE;INJECTION 065214-001 Mar 10, 2006 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
B Braun CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER cefoxitin sodium INJECTABLE;INJECTION 065214-002 Mar 10, 2006 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Queensland Health
Teva
Farmers Insurance
Julphar
US Army
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.